• roomer_BANERER_01

ʻO ka holomua noiʻiʻana o Opido Peptides mai kaʻaeʻana o kaʻaeʻana

E like me ka 2021-08-24,ʻo Cara Therapeutics a me kānaʻoihanaʻo Vafor Prinings 20224. Ua kau inoaʻo Cara a me VIFOR i kahi palapala laikini kūʻokoʻa no ke kālepaʻana o Korsuva ™ maʻAmelika Hui PūʻIa. I waena o lākou,ʻo CARA a me Vifor i kēlā me kēia he 60% a me 40% paha ka loaʻa kālā ma mua o ka loaʻa kālā Loaʻa i kēlā me kēia he 50% kālā kālā ma ke kālā kūʻai aku mai ka loaʻaʻana o Fresenius.

ʻO CKD-pili i ka priritus (ckd-ap) he priritus ākea nui e hele me ka nui a me ka ikaika ma ka maʻi ckd ma mua o ka dialysis. Aiaʻo Priritus ma kahi o 60% -70% o nā mea maʻi e loaʻa ana i ka dialysis ʻAʻohe mea kūpono kūpono no ka PPD-Pritutus e pili ana i ka CKD ma mua, aʻo kaʻaeʻia o kaʻaeʻana e kōkua i ka pono o ke kauka nui. Kuhiʻia kēiaʻaeʻia ma nā hoʻokolohuaʻo PIVOL ma keʻano heihei i ka NDA Filling

ʻAʻole i lōʻihi ka lōʻihi,ʻo ka nūhou maikaʻi mai ke aʻoʻana o keʻano o ka mea e pono ai ma Iapana a me ka mālamaʻana o kona mau hoa ma nā mea maʻiʻo Maruishil ma Iapana. Ua hālāwai nā hoʻokolohua Iii Cilillical i nā hoʻokolohuaʻo Phase III. He 178 Loaʻa nā poʻe maʻi he 6 mau pule o ka dcuelikefallin a iʻole placebo a komo i loko o kahi papa inoa inoaʻo 52-wiki. ʻO ka hopena mua (e hoʻololi i ka helu helu Priritus helu helu helu helu) a me ka liʻiliʻi o ka heluʻana i ka scatelity ma keʻano he scalinefal ma keʻano he stralinefalin i ka huiʻana o ka moku

ʻO kaʻaoʻao o keʻano he papa o nā pepoid opioid opioid. Wahi a kēia, ua aʻoʻiaʻo PerPide Institute Institute ma Opid Peptides a me nā hoʻolālā o ka hoʻolālāʻana i ka lāʻau lapaʻau.

KūbitaffI manaʻohana


Post Time: Feb-17-2022